Resection of residual retroperitoneal masses in testicular cancer: Evaluation and improvement of selection criteria

British Journal of Cancer

Volumn 74, Issue 9, 1996, Pages 1492-1498

  Steyerberg, E W ^a   Keizer, H J ^b   Fossa S D ^c   Sleijfer, D T ^d   Bajorin, D F ^e   Donohue, J P ^f   Habbema, J D F ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f INDIANA UNIVERSITY   (United States)

Author keywords

Resection; Residual mass; Testicular cancer

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; LACTATE DEHYDROGENASE;

ARTICLE; HUMAN; LYMPH NODE DISSECTION; MALE; MINIMAL RESIDUAL DISEASE; NON SEMINOMATOUS GERMINOMA; PATIENT SELECTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; RETROPERITONEUM; TESTIS CANCER;

EID: 0029799904     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.571     Document Type: Article

References (33)

1. AASS N, KLEPP O, CAVILLIN-STÅHL E, DAHL O, WICKLUND H, UNSGAARD B, BALDETORP L, AHLSTRÖM S AND FOSSÅ SD. (1991). Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience. J. Clin. Oncol., 9, 818-826.
2. BEGG CB AND GREENES RA. (1983). Assessment of diagnostic tests when disease verification is subject to selection bias. Biometrics, 39, 207-215.
3. DE GRAAF WE, OOSTERHUIS JW, VAN DER LINDEN S, HOMAN VAN DER HEIDE JN, SCHRAFFORDT KOOPS H AND SLEIJFER DTh. (1991). Residual mature teratoma after chemotherapy for nonseminomatous germ cell tumours of the testis occurs significantly less often in lung than in retroperitoneal lymph node metastases. J. Urogen. Pathol., 1, 75-81.
4. DONOHUE JP, ROWLAND RG, KOPECKY K, STEIDLE CP, GEIER G, NEY KG, EINHORN L, WILLIAMS S AND LOEHRER P. (1987). Correlation of computerized tomographic changes and histological findings in 80 patients having radical retroperitoneal lymph node dissection after chemotherapy for testis cancer. J. Urol., 137, 1176-1179.
5. EFRON B. (1983). Estimating the error rate of a prediction rule: improvement on cross-validation. J. Am. Stat. Assoc., 78, 316-331.
6. EINHORN LH, WILLIAMS SD, MANDELBAUM I AND DONOHUE JP. (1981). Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreduction. Cancer, 48, 904-908.
7. EINHORN LH. (1990). Treatment of testicular cancer: a new and improved model. J. Clin. Oncol., 8, 1777-1781.
8. FOSSA SD, OUS S, LIEN HH AND STENWIG AE. (1989a). Post-chemotherapy lymph node histology in radiologically normal patients with metastatic nonseminomatous testicular cancer. J. Urol., 141, 557-559.
9. FOSSÅ SD, AASS N, OUS S, HØIE J, STENWIG AE, LIEN HH, PAUS E AND KAALHUS O. (1989b). Histology of tumour residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer. J. Urol., 142, 1239-1242.
10. FOSSAØ SD, QVIST H, STENWIG AE, LIEN HH, OUS S AND GIERCKSKY KE. (1992). Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumour masses? Clin. Oncol., 10, 569-573.
11. FOX EP, WEATHERS TD, WILLIAMS SD, LOEHRER PJ, ULBRIGHT TM, DONOHUE JP AND EINHORN LH. (1993). Outcome analysis for patients with persistent nonteratomatous germ cell tumour in postchemotherapy retroperitoneal lymph node dissections. J. Clin. Oncol., 11, 1294-1299.
12. GELDERMAN WAH, SCHRAFFORDT KOOPS H, SLEIJFER DTh, OOSTERHUIS JW AND OLDHOFF J. (1986). Treatment of retroperitoneal residual tumour after PVB chemotherapy of nonseminomatous testicular tumours. Cancer. 58, 1418-1421.
13. GELDERMAN WAH, SCHRAFFORDT KOOPS H, SLEIJFER DTh, OOSTERHUIS JW, HOMAN VAN DER HEIDE JN, MULDER NH, MARRINK J, BRUYN HWA DE AND OLDHOFF J. (1988). Results of adjuvant surgery in patients with stage III and IV nonseminomatous testicular tumours after cisplatin-vinblastinebleomycin chemotherapy. J. Surg. Oncol., 38, 227-232.
14. GERL A, CLEMM C, SCHMELLER N, DIENEMANN H, LAMERZ R, KRIEGMAIR M AND WILMANNS W. (1995). Outcome analysis after post-chemotherapy surgery in patients with non-seminomatous germ cell tumours. Ann. Oncol., 6, 483-488.
15. HARDING MJ, BROWN IL, MACPHERSON SG, TURNER MA AND KAYE SB. (1989). Excision of residual masses after platinum based chemotherapy for non-seminomatous germ cell tumours. Eur. J. Cancer Clin. Oncol., 25, 1689-1694.
16. HARRELL FE, CALIFF RM, PRYOR DB, LEE KL AND ROSATI RA. (1982). Evaluating the yield of medical tests. J. Am. Med. Assoc., 247, 2543-2546.
17. HENDRY WF, A'HERN RP, HETHERINGTON JW, PECKHAM MJ, DEARNALEY DP AND HORWICH A. (1993). Para-aortic lymphadenectomy after chemotherapy for metastatic nonseminomatous germ cell tumours: prognostic value and therapeutic benefit. Br. J. Urol., 71, 208-213.
18. HILDEN J. (1991). The area under the ROC curve and its competitors. Med. Decision Making, 11, 95-101.
19. JANSEN RLH, SYLVESTER R, SLEIJFER DT, BOKKEL HUININK WW TEN, KAYE SB, JONES WG, KEIZER J, OOSTEROM AT VAN, MEYER S, VENDRIK CPJ, PAUW M DE AND STOTER G (1991). Long-term follow-up of non-seminomatous testicular cancer patients with mature teratoma or carcinoma at postchemotherapy surgery. Eur. J. Cancer, 27, 695-698.
20. LOGOTHETIS CJ, SAMUKLS ML, TRINDADE A AND JOHNSON DE. (1982). The growing teratoma syndrome. Cancer, 50, 1629-1635.
21. MCNEMAR Q. (1947). Note on the sampling error of the difference between correlated proportions or percentages. Psychometrica, 12, 153 157.
22. MEAD GM, STENNING SP, PARKINSON MC, HORWICH A, FOSSÅ SD, WILKINSON PM, KAYK SB, NEWLANDS ES AND COOK PA. (1992). The second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumours. J. Clin. Oncol., 10, 85 94.
23. MULDKRS PFA, OOSTERHOF GON, BOETES C, MULDER PHM DE, THEEUWES AGM AND DEBRUYNE FMJ. (1990). The importance of prognostic factors in the individual treatment of patients with disseminated germ cell tumours. Br. J. Vrol., 66, 425 429.
24. NIJMAN JM, SCHRAFFORDT KOOPS H, KREMER J AND SLEIJFER DT. (1987). Gonadal function after surgery and chemotherapy in men with stage II and III nonseminomatous testicular tumours. J. Clin. Oncol., 5, 651-656.
25. PECKHAM M. (1988). Testicular cancer. Rev. Oncol., 1, 439 453.
26. RANSOHOFF DF AND FEINSTEIN AR. (1978). Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N. Engl. J. Med., 299, 926 930.
27. SOX HCJR, BLATT MA, HIGGINS MC AND MARTON KI. (1988). Medical Decision Making. Butterworths: Boston.
28. STEYERBERG EW, KEIZER HJ, ZWARTKNDIJK J, RIJK VAN GL, GROENINGEN CJ VAN, HABBEMA JDK AND STOTER G. (1993). Prognosis after resection of residual masses following chemotherapy for metastatic nonseminomatous testicular cancer: a multivariate analysis. Br. J. Cancer, 68, 195 200.
29. STEYERBERG eW, KEIZER HJ, STOTER G AND HABBEMA JDF. (1994). Predictors of residual mass histology following chemotherapy for metastutic nonseminomatous testicular cancer: a quantitative overview of 996 resections. Eur. J. Cancer, 30A, 1231-1239.
30. STEYERBERG EW, KEIZER HJ, FOSSÅ SD, SLEIJFER DT, TONER GC, SCHRAFFORDT KOOPS H, MULDERS PFA, MESSEMER JE, NEY K, DONOHUE JP, BAJORIN D, STOTER G, BOSL GJ AND HABBEMA JDF. (1995). Prediction of residual retroperitoneal mass histology following chemotherapy for metastatic nonseminomatous germ cell tumour: multivariate analysis of individual patient data from 6 study groups. J. Clin. Oncol., 13, 1177 1187.
31. TAIT D, PECKHAM MJ, HENDRY WF AND GOLDSTRAW P. (1984). Post-chemotherapy surgery in advanced non-seminomatous germ-cell tumours: the significance of histology with particular reference to differentiated (mature) teratoma. Br. J. Cancer, 50, 601 609.
32. TONER GC, PANICEK DM, HEELAN RT, GELLER NL, LIN S-Y, BAJORIN D, MOTZER RJ, SCHER HI, HERR HW, MORSE MJ, FAIR WR, SOGANI PC, WHITMORE WF, MCCORMACK PM, BAINS MS, MARTINI N AND BOSL GJ. (1990). Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumotirs: recommendations for patient selection. J. Clin. Oncol., 8, 1683 1694.
33. VAN DER SCHOUW YT, STRAATMAN H AND VERBEEK ALM. (1994). ROC curves and the areas under them for dichotomized tests: empirical findings for logistically and normally distributed diagnostic test results. Med. Decision Making, 14, 374 381.